Marjolein de Bruin-Weller
0000-0002-1249-6993
11 papers found
Refreshing results…
Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
EASI p‐EASI: predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity
Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
EASI p‐ EASI : Predicting disease severity in atopic dermatitis patients treated with cyclosporin A
Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology
Missing publications? Search for publications with a matching author name.